Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety of Ocrelizumab In Comparison To Interferon Beta-1a In Patients With Relapsing Multile Sclerosis

Project: Research

Project Details

StatusFinished
Effective start/end date01/5/12 → 06/30/14

Funding

  • Quintiles Incorporated: $12,500.00